U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Public Hearing on Use of Medication Guides to Distribute Drug Risk Information to Patients June 12-13, 2007
  1. Drug Safety and Availability

Public Hearing on Use of Medication Guides to Distribute Drug Risk Information to Patients June 12-13, 2007

Public Hearing on Use of Medication Guides to Distribute Drug Risk Information to Patients June 12-13, 2007

On June 12-13, 2007, FDA’s Center for Drug Evaluation and Research (CDER) will hold a public hearing to obtain feedback on FDA’s Medication Guide program, which provides for the distribution of FDA-approved written patient information for certain drug and biological products that pose serious and significant public health concerns. FDA is interested in obtaining public comment on ways to improve communication to patients who receive Medication Guides. The purpose of the public hearing is to solicit information and views from interested persons on specific issues associated with the development, distribution, comprehensibility, and accessibility of Medication Guides, which are required to convey risk information to patients.

Summary of Public Hearing on FDA's Use of Medication Guides to Distribute Drug Risk Information to Patients June 12-13, 2007

Dates:          June 12-13, 2007
Time:           8:30 a.m. – 4:30 p.m.
Location:     National Transportation and Safety Board (NTSB)
                    Boardroom and Conference Center
                    429 L’Enfant Plaza, SW
                    Washington, DC 20594
                    Metro: L’Enfant Plaza Station on the Green, Yellow, Blue, and Orange Lines.

 

Back to Top